News list for " nine prices"

On August 26th, Wantai Bio announced in the evening that the application for marketing authorization of the nine-valent HPV vaccine jointly developed by Wantai Canghai, a wholly-owned subsidiary of the company, and Xiamen University has been accepted by the Drug Evaluation Center of the State Food and Drug Administration. According to the "Drug Registration Administration Measures", the State Food and Drug Administration will conduct a technical review of the safety, efficacy and quality control...

2024-08-26 15:58:17